WMSA
VERA icon

Weiss Multi-Strategy Advisers’s Vera Therapeutics VERA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-76,224
Closed -$1.17M – 459
2023
Q4 		$1.17M Buy
76,224
+31,032
+69% +$394K 0.03% 417
2023
Q3 		$620K Sell
45,192
-34,808
-44% -$597K 0.01% 465
2023
Q2 		$1.28M Buy
+80,000
New +$723K 0.03% 520

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's VERA Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Vera Therapeutics (VERA) in Q1 2024, closing a stake of 76,224 shares — an estimated $1.17M sold.

Weiss Multi-Strategy Advisers first reported a position in VERA in Q2 2023 and held it in 3 quarters. The position peaked at $1.28M in Q2 2023. 160 funds tracked by Wall St. Rank hold VERA as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Vera Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 76,224 Vera Therapeutics shares in Q1 2024, an estimated $1.17M.
  • Weiss Multi-Strategy Advisers first reported a position in Vera Therapeutics in Q2 2023 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Vera Therapeutics position peaked at $1.28M in Q2 2023.
  • 160 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.